Software as a Medical Device (SaMD) developers working with artificial intelligence and machine learning components face a...
De Novo
Deciding whether to choose QMS or De Novo for SaMD in trials is one of the most...
When a digital health company plans a clinical trial for a new medical device, the first strategic...
Securing FDA approval for a low-cost digital therapeutics (DTx) platform is a formidable but achievable goal. By...
For founders building the next generation of evidence‑based digital therapeutics, the 2024 FDA approval pathway can feel...